for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-AstraZeneca Exec Says Co's COVID Vaccine Supply Plan Same Worldwide - Interview

Nov 5 (Reuters) - AstraZeneca Executive Mene Pangalos In Interview:

* SAYS CO’S COVID-19 VACCINE STORAGE, DISTRIBUTION AND SUPPLY STRAGEGY IS SAME WORLDWIDE

* SAYS READOUT ON COVID VACCINE DATA COULD BE NOV/DEC, DEPENDING ON NUMBER OF INFECTIONS IN TRIALS, INDICATION FROM MONITORING BOARD

* SAYS TRIAL DESIGN AND INFECTION NUMBERS THAT TRIGGER READOUT IN UK IS SIMILAR TO U.S. COVID-19 VACCINE TRIAL BUT NOT IDENTICAL

* SAYS U.S. COVID-19 VACCINE STUDY WILL BE A CONFIRMATORY STUDY OF THE RESULTS FROM OXFORD STUDIES IN UK, BRAZIL AND SOUTH AFRICA

* SAYS NO SPECIFICATION SO FAR FROM U.S. FDA ON WHERE THE DATA MUST COME FROM FOR EMERGENCY AUTHORISATION OF COVID-19 VACCINE

* SAYS IF EFFICACY, SAFETY, STATISTICAL SIGNIFICANCE FROM UK, S.AFRICA & BRAZIL TRIALS ARE SATISFACTORY, WILL START DISCUSSION WITH U.S. FDA ON EUA

* SAYS WILL NOT HAVE PROBLEM RECRUITING VOLUNTEERS FOR PLACEBO-CONTROLLED VACCINE TRIAL AFTER ANY APPROVAL AS WIDE ROLLOUT WILL TAKE MONTHS Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up